Journal for ImmunoTherapy of Cancer (Feb 2022)

PAD-2-mediated citrullination of nucleophosmin provides an effective target for tumor immunotherapy

Victoria A Brentville,
Rachael L Metheringham,
Ian Daniels,
Peter Symonds,
Katherine W Cook,
Mohamed Gijon,
Lindy G Durrant,
Ruhul H Choudhury,
Samantha J Paston

Affiliations

Victoria A Brentville: Scancell Ltd, Nottingham, UK
Rachael L Metheringham: Scancell Ltd, Nottingham, UK
Ian Daniels: Scancell Ltd, Nottingham, UK
Peter Symonds: Scancell Ltd, Nottingham, UK
Katherine W Cook: Scancell Ltd, Nottingham, UK
Mohamed Gijon: Scancell Ltd, Nottingham, UK
Lindy G Durrant: Scancell Ltd, Nottingham, UK
Ruhul H Choudhury: Scancell Ltd, Nottingham, UK
Samantha J Paston: Scancell Ltd, Nottingham, UK

DOI: https://doi.org/10.1136/jitc-2021-003526
Journal volume & issue: Vol. 10, no. 2

Abstract

No abstracts available.

Published in Journal for ImmunoTherapy of Cancer

ISSN: 2051-1426 (Online)
Publisher: BMJ Publishing Group
Country of publisher: United Kingdom
LCC subjects: Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Website: https://jitc.bmj.com

About the journal